Koneksa's digital biomarker platform uses best-in-class advanced algorithms to analyze and integrate real-time patient data in clinical trials from multiple wearables and sensors to create a single, seamless experience for patients, sponsors and research organizations.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/07/22	$45,000,000	Series C	AyurMaya dRx Capital McKesson Ventures Merck Global Health Innovation Fund Takeda Ventures Velosity Capital Waterline Ventures	undisclosed